NCT01150305

Brief Summary

Hearing impairment is a common disorder that affects at least 7% of individuals in our countries. Even the causes of hearing impairment are numerous, genetic causes represent the main factor of sensorineural deafness. Among hereditary non-syndromic deafness autosomal-dominant inheritance is observed in about 10-20% of the cases. These forms of deafness are usually post-lingual and progressive. To date more than 41 chromosomal localisation and 21 genes associated to non syndromic dominant deafness have been described. It represents an extreme genetic heterogeneity making difficult the studies of these forms of hearing impairment. But, genetic diagnostic testing is crucial in these cases. Indeed, therapeutic research are in the way to prevent the progression of the disorder. The aim of this work is to establish the prevalence of the different genes involved in these forms of deafness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
183

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2009

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

March 29, 2010

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 24, 2010

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2012

Completed
Last Updated

August 7, 2013

Status Verified

August 1, 2013

Enrollment Period

3 years

First QC Date

March 29, 2010

Last Update Submit

August 6, 2013

Conditions

Keywords

Autosomal dominant inheritanceMutationPrevalence

Outcome Measures

Primary Outcomes (1)

  • The identification of a deleterious mutation of a gene coding a protein present in the cochlea

    1 day

Secondary Outcomes (1)

  • The phenotype genotype relationships after identification of the causative gene and mutation

    1 day

Study Arms (2)

1

Patient presenting familial dominant non syndromic hearing loss starting between 4 and 40 years old, over 2 generations

Biological: blood sample

2

Healthy volunteer from the same families

Biological: blood sample

Interventions

blood sampleBIOLOGICAL

Peripheral whole blood sample, 5 ml

12

Eligibility Criteria

Age4 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

families with non syndromic dominant hearing impairment followed by the clinical investigators

You may qualify if:

  • Age \> 4 years.
  • Patient presenting familial dominant non syndromic hearing loss starting between 4 and 40 years old, over 2 generations
  • Healthy volunteer from the same families
  • Clinical and paraclinical assessment (genetic and ophthalmologic examination, audiometric tests, inner ear CT scan)
  • Affiliated to the national health insurance benefit
  • Signature of informed consent form

You may not qualify if:

  • hearing loss resulting from an extrinsic reason or an associated syndrome
  • Defective or insufficient samples
  • No or insufficient clinical and biological description
  • No informed consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Armand-Trousseau, Service d'ORL pédiatrique et de Chirurgie Maxillo Faciale

Paris, 75012, France

Location

Biospecimen

Retention: SAMPLES WITH DNA

Peripheral whole blood

MeSH Terms

Conditions

Hearing LossMultiple Pterygium Syndrome, Autosomal Dominant

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Françoise Denoyelle, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2010

First Posted

June 24, 2010

Study Start

April 1, 2009

Primary Completion

April 1, 2012

Study Completion

April 1, 2012

Last Updated

August 7, 2013

Record last verified: 2013-08

Locations